• Home
  • Team
  • Research & Development
    • ADA-308 technology
    • Pipeline
    • ADA-308 for androgenetic alopecia
    • ADA-308 for acne
    • ADA-409 for brain diseases
  • Contact us
  • News
Aranda Pharma Ltd.
  • Home
  • Team
  • Research & Development
    • ADA-308 technology
    • Pipeline
    • ADA-308 for androgenetic alopecia
    • ADA-308 for acne
    • ADA-409 for brain diseases
  • Contact us
  • News

ADA-409 for brain diseases

Brain diseases

Ferroptosis is iron-dependent cell death caused by accumulation of lipid peroxidation. It was recently discovered to be a major pathway leading to cell death in e.g. Parkinson’s disease, Alzheimer’s disease, ALS and acute brain insults, and hence inhibition of ferroptosis has become one of novel therapeutic strategies for brain diseases. Aranda’s proprietary ADA-409 small molecules strongly inhibit lipid peroxidation and protect against ferroptotic cell death. The data has been published in collaboration with University of Eastern Finland and University of Helsinki (Keuters et al., 2021).

Aranda Pharma Ltd

Microkatu 1
P.O. Box 1199
FI-70211 Kuopio
Finland
Terkko Health Hub
Haartmaninkatu 4, Building 14
FI-00290, Helsinki
Finland
Follow us in LinkedIn
Picture
  • Home
  • Team
  • Research & Development
    • ADA-308 technology
    • Pipeline
    • ADA-308 for androgenetic alopecia
    • ADA-308 for acne
    • ADA-409 for brain diseases
  • Contact us
  • News